All oncologists know how anxiously cancer patients look forward to the availability in clinical practice of drugs that have yielded positive results in the registration trials.
Primary tabs
Focus on
In the form of questions and answers the topic of vertigo in hypothyroid subjects is discussed, with particular reference to the possibility that it is an adverse drug reaction. Or maybe not?Can the appearance of vertigo in a patient undergoing therapy with levothyroxine be an adverse event due to...
Columns
Drugs & Elderly
In recent years, the concept of deprescribing has been introduced, based on the reduction of the number of drugs taken in order to optimize the risk-benefit ratio of polypharmacy taking into account the goals of treatment and the preferences of the patient; however, the available intervention...
From regulatory agencies
| 30 January 2023 CADTH | 30 January 2023 FDA |
| 30 January 2023 FDA | 27 January 2023 FDA |
| 27 January 2023 FDA | 26 January 2023 CADTH |
| 26 January 2023 FDA | 25 January 2023 FDA |
| 25 January 2023 FDA | 20 January 2023 CADTH |